Christopher Stone
2019
In 2019, Christopher Stone earned a total compensation of $2.5M as Vice President, General Counsel and Secretary at PDL BioPharma, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $645,129 |
|---|---|
| Option Awards | $1,300,000 |
| Salary | $497,490 |
| Other | $10,000 |
| Total | $2,452,619 |
Stone received $1.3M in option awards, accounting for 53% of the total pay in 2019.
Stone also received $645.1K in non-equity incentive plan, $497.5K in salary and $10K in other compensation.
Rankings
In 2019, Christopher Stone's compensation ranked 4,949th out of 13,971 executives tracked by ExecPay. In other words, Stone earned more than 64.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,949 out of 13,971 | 65th |
Division Manufacturing | 1,842 out of 5,692 | 68th |
Major group Chemicals And Allied Products | 650 out of 2,189 | 70th |
Industry group Drugs | 549 out of 1,875 | 71st |
Industry Biological Products, Except Diagnostic Substances | 122 out of 389 | 69th |
Source: SEC filing on July 7, 2020.
Stone's colleagues
We found four more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2019.